Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
03 2022
Historique:
received: 24 01 2021
revised: 04 03 2021
accepted: 04 04 2021
pubmed: 20 4 2021
medline: 9 6 2022
entrez: 19 4 2021
Statut: ppublish

Résumé

Correct identification of variant histologies (VHs) of bladder cancer (BCa) at transurethral resection of the bladder (TURB) could drive the subsequent treatment. To evaluate the concordance in detecting VHs between TURB and radical cystectomy (RC) specimens in BCa patients. We retrospectively analyzed 1881 BCa patients who underwent TURB and subsequent RC at seven tertiary care centers between 1980 and 2018. VHs were classified as sarcomatoid, lymphoepithelioma-like, neuroendocrine, squamous, micropapillary, glandular, adenocarcinoma, nested, and other variants. Concordance between TURB and RC was defined as the ability to achieve histological subtypes at TURB confirmed at RC specimen, and was expressed according to Cohen's kappa coefficient. Of the patients, 14.6% and 21% were diagnosed with VH at TURB and RC specimens, respectively. The most common VHs at TURB were squamous, neuroendocrine, and micropapillary carcinoma (5.2%, 1.5%, and 1.5%, respectively). At RC, the most frequent VHs were squamous, micropapillary, and sarcomatoid carcinoma (7.2%, 3.0%, and 2.7%, respectively). The overall concordance in detecting VH was defined as slight concordance (coefficient: 0.18). Moderate concordance was found for neuroendocrine, adenocarcinoma, and squamous carcinoma (coefficient: 0.49, 0.47, and 0.41, respectively). Micropapillary, glandular, and other variants showed slight concordance (coefficient: 0.05, 0.17, and 0.12, respectively), while nested and sarcomatoid carcinoma showed fair concordance (coefficient: 0.32 and 0.26, respectively). Results may be limited by the absence of centralized pathological analysis. A non-negligible percentage of patients were diagnosed with VH at both TURB and RC. TURB showed relatively low accuracy, ranging from poor to moderate, in detecting VHs. Our study underlines the need of additional diagnostic tools in order to identify VHs properly at precystectomy time and to improve patient survival outcomes. In this report, we underlined the low accuracy of transurethral resection of the bladder in detecting variant histologies and the need for additional diagnostic tools.

Sections du résumé

BACKGROUND
Correct identification of variant histologies (VHs) of bladder cancer (BCa) at transurethral resection of the bladder (TURB) could drive the subsequent treatment.
OBJECTIVE
To evaluate the concordance in detecting VHs between TURB and radical cystectomy (RC) specimens in BCa patients.
DESIGN, SETTING, AND PARTICIPANTS
We retrospectively analyzed 1881 BCa patients who underwent TURB and subsequent RC at seven tertiary care centers between 1980 and 2018. VHs were classified as sarcomatoid, lymphoepithelioma-like, neuroendocrine, squamous, micropapillary, glandular, adenocarcinoma, nested, and other variants.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS
Concordance between TURB and RC was defined as the ability to achieve histological subtypes at TURB confirmed at RC specimen, and was expressed according to Cohen's kappa coefficient.
RESULTS AND LIMITATIONS
Of the patients, 14.6% and 21% were diagnosed with VH at TURB and RC specimens, respectively. The most common VHs at TURB were squamous, neuroendocrine, and micropapillary carcinoma (5.2%, 1.5%, and 1.5%, respectively). At RC, the most frequent VHs were squamous, micropapillary, and sarcomatoid carcinoma (7.2%, 3.0%, and 2.7%, respectively). The overall concordance in detecting VH was defined as slight concordance (coefficient: 0.18). Moderate concordance was found for neuroendocrine, adenocarcinoma, and squamous carcinoma (coefficient: 0.49, 0.47, and 0.41, respectively). Micropapillary, glandular, and other variants showed slight concordance (coefficient: 0.05, 0.17, and 0.12, respectively), while nested and sarcomatoid carcinoma showed fair concordance (coefficient: 0.32 and 0.26, respectively). Results may be limited by the absence of centralized pathological analysis.
CONCLUSIONS
A non-negligible percentage of patients were diagnosed with VH at both TURB and RC. TURB showed relatively low accuracy, ranging from poor to moderate, in detecting VHs. Our study underlines the need of additional diagnostic tools in order to identify VHs properly at precystectomy time and to improve patient survival outcomes.
PATIENT SUMMARY
In this report, we underlined the low accuracy of transurethral resection of the bladder in detecting variant histologies and the need for additional diagnostic tools.

Identifiants

pubmed: 33867307
pii: S2405-4569(21)00111-5
doi: 10.1016/j.euf.2021.04.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

457-464

Informations de copyright

Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Chiara Lonati (C)

Department of Urology, Spedali Civili of Brescia, Brescia, Italy; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: chiara.lonati@libero.it.

Philipp Baumeister (P)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Paola Irene Ornaghi (PI)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Ettore Di Trapani (E)

Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.

Ottavio De Cobelli (O)

Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy; Università degli Studi di Milano, Department of Oncology and Hematology-Oncology, Milan, Italy.

Michael Rink (M)

Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Robert Jeffrey Karnes (RJ)

Department of Urology, Mayo Clinic, Rochester, MN, USA.

Cédric Poyet (C)

Department of Urology, University Hospital Zürich, Zürich, Switzerland.

Giuseppe Simone (G)

Department of Urology, "Regina Elena" National Cancer Institute, IRCCS, Rome, Italy.

Luca Afferi (L)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Andrea Necchi (A)

Department of Medical Oncology, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.

Alberto Briganti (A)

Department of Urology, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.

Francesco Montorsi (F)

Department of Urology, IRCCS San Raffaele Hospital and Vita-Salute San Raffaele University, Milan, Italy.

Wojciech Krajewski (W)

Department of Urology and Oncological Urology, Wrocław Medical University, Wrocław, Poland.

Alessandro Antonelli (A)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Maria Angela Cerruto (MA)

Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Stefania Zamboni (S)

Department of Urology, Spedali Civili of Brescia, Brescia, Italy.

Claudio Simeone (C)

Department of Urology, Spedali Civili of Brescia, Brescia, Italy.

Livio Mordasini (L)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Agostino Mattei (A)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Marco Moschini (M)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH